Clinical trial
Genomic Testing and Resulting Medical Decisions
NCT03301493
Study timeline
Study start (actual)2017-03-30Date precision: day
Registry last updated2025-04-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Cancer of Unknown Originunresolved
Cancer Refractoryunresolved
Cancer of Stomachverified · MONDO: gastric cancer
Cancer Head Neckunresolved
Cancer of Skinunresolved
Cancer, Lungcandidate · MONDO: lung cancer
Cancer Colorectalunresolved
Cancer of Esophagusverified · MONDO: esophageal cancer
Cancer, Bladderunresolved
Cancer, Uteruscandidate · MONDO: uterine cancer
Cancer Cervixunresolved
Cancer Liverunresolved
Cancer, Kidneycandidate · MONDO: kidney cancer
Cancer, Breastcandidate · MONDO: breast cancer
Hematologic Neoplasmsunresolved
Interventions
Genomic testingOTHER
Sponsors & collaborators
Arbeitsgemeinschaft medikamentoese Tumortherapielead sponsor
Roche Pharma AGcollaborator
AstraZenecacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03301493 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.